<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PROMETHAZINE HYDROCHLORIDE</span><br/>(proe-meth'a-zeen)<br/><span class="topboxtradename">Histantil <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Pentazine, </span><span class="topboxtradename">Phencen, </span><span class="topboxtradename">Phenergan, </span><span class="topboxtradename">Phenoject-50, </span><span class="topboxtradename">Prometh, </span><span class="topboxtradename">Prorex, </span><span class="topboxtradename">Prothazine, </span><span class="topboxtradename">V-Gan<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">antiemetic</span>; <span class="classification">antivertigo agent</span>; <span class="classification">phenothiazine</span><br/><b>Prototype: </b>Prochlorperazine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>12.5 mg, 25 mg, 50 mg tablets; 6.25 mg/5 mL syrup; 12.5 mg, 25 mg, 50 mg suppositories; 25 mg/mL, 50 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Long-acting derivative of phenothiazine with marked antihistamine activity and prominent sedative, amnesic, antiemetic, and
         anti-motion-sickness actions. Unlike other phenothiazine derivatives, relatively free of extrapyramidal adverse effects; however,
         in high doses it carries same potential for toxicity.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>In common with other antihistamines, exerts antiserotonin, anticholinergic, and local anesthetic action. Antiemetic action
         thought to be due to depression of CTZ in medulla.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Symptomatic relief of various allergic conditions, to ameliorate and prevent reactions to blood and plasma, and in prophylaxis
         and treatment of motion sickness, nausea, and vomiting. Preoperative, postoperative, and obstetric sedation and as adjunct
         to analgesics for control of pain.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to phenothiazines; narrow-angle glaucoma; stenosing peptic ulcer, pyloroduodenal obstruction; prostatic hypertrophy;
         bladder neck obstruction; epilepsy; bone marrow depression; comatose or severely depressed states; pregnancy (category C),
         lactation, newborn or premature infants, acutely ill or dehydrated children; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired liver function; cardiovascular disease; asthma; acute or chronic respiratory impairment (particularly in children);
         hypertension; older adult or debilitated patients; children &gt;2 y.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Motion Sickness</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/PR/IM/IV</span> 25 mg b.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">PO/PR/IM/IV</span> 12.525 mg b.i.d.<br/><br/><span class="indicationtitle">Nausea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/PR/IM/IV</span> 12.525 mg q46h prn<br/><span class="rdage">Child:</span> <span class="rdroute">PO/PR/IM/IV</span> 0.250.5 mg/kg q46h prn<br/><br/><span class="indicationtitle">Allergies</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/PR/IM/IV</span> 12.5 mg q.i.d. or 25 mg h.s.<br/><span class="rdage">Child:</span> <span class="rdroute">PO/PR/IM/IV</span> 6.2512.5 mg q.i.d. or 25 mg h.s.<br/><br/><span class="indicationtitle">Sedation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/PR/IM/IV</span> 2550 mg preoperatively or h.s.<br/><span class="rdage">Child:</span> <span class="rdroute">PO/PR/IM/IV</span> 12.525 mg preoperatively or h.s.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food, milk, or a full glass of water may minimize GI distress.</li>
<li>Tablets may be crushed and mixed with water or food before swallowing.</li>
<li>Oral doses for allergy are generally prescribed before meals and on retiring or as single dose at bedtime.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give IM injection deep into large muscle mass. Aspirate carefully before injecting drug. Intraarterial injection can cause
            arterial or arteriolar spasm, with resultant gangrene. Subcutaneous injection (also contraindicated) can cause chemical irritation
            and necrosis. Rotate injection sites and observe daily.
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span>  Concentrations of 25 mg/mL or less may be given undiluted. Dilute more concentrated preparations in NS to yield no more than
                  25 mg/mL (e.g., diluting the 50 mg/mL concentration in 9 mL yields 5 mg/mL). Inspect parenteral drug before preparation. Discard if it is darkened or contains precipitate. 
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give each 25 mg over at least 1 min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>Aminophylline,</b>
<b>carbenicillin,</b>
<b>cefotetan,</b>
<b>chloramphenicol,</b>
<b>chlorothiazide,</b>
<b>heparin,</b>
<b>hydrocortisone,</b>
<b>methicillin,</b>
<b>methohexital,</b>
<b>penicillin G sodium,</b>
<b>pentobarbital,</b>
<b>phenobarbital,</b>
<b>thiopental,</b>
<b>diatrizoate,</b>
<b>dimenhydrinate,</b>
<b>iodipamide,</b>
<b>iothalamate,</b>
<b>nalbuphine.</b>
<span class="incompattype">Y-site:</span>
<b>Aldesleukin,</b>
<b>allopurinol,</b>
<b>amphotericin B cholesteryl complex,</b>
<b>cefepime,</b>
<b>cefoperazone,</b>
<b>cefotetan,</b>
<b>doxorubicin liposome,</b>
<b>foscarnet,</b>
<b>heparin,</b>
<b>methotrexate.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store at 15°30° C (59°86° F) in tight, light-resistant container unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Deep sleep, coma, convulsions, cardiorespiratory symptoms, extrapyramidal reactions, nightmares (in children), CNS stimulation,
      abnormal movements. <span class="typehead">Respiratory:</span> Irregular respirations, <span class="speceff-life">respiratory depression, apnea</span>. <span class="typehead"> CNS:</span> Sedation <span class="speceff-common">drowsiness,</span> confusion, dizziness, disturbed coordination, restlessness, tremors. <span class="typehead">CV:</span> Transient mild hypotension or hypertension. <span class="typehead">GI:</span> Anorexia, nausea, vomiting, constipation. <span class="typehead"> Hematologic:</span> Leukopenia, <span class="speceff-life">agranulocytosis</span>. <span class="typehead">Special Senses:</span>
<span class="speceff-common">Blurred vision, dry mouth,</span> nose, or throat. <span class="typehead">Skin:</span> Photosensitivity. <span class="typehead">Urogenital:</span> Urinary retention. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Promethazine may interfere with <span class="alt">blood grouping in ABO system</span> and may produce false results with <span class="alt">urinary pregnancy tests</span> (<span class="alt">Gravindex,</span>
<span class="alt">false-positive;</span>
<span class="alt">Prepurex</span> and <span class="alt">Dap tests,</span> false-negative). Promethazine can cause significant alterations of <span class="alt">flare response</span> in <span class="alt">intradermal allergen tests</span> if performed within 4 d of patient's receiving promethazine.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> and other <span class="classification">cns depressants</span> add to CNS depression and anticholinergic effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 20 min PO/PR/IM; 5 min IV. <span class="typehead">Duration:</span>  28 h. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead">Metabolism:</span>  Metabolized in liver. <span class="typehead"> Elimination:</span> Slowly excreted in urine and feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Supervise ambulation. Promethazine sometimes produces marked sedation and dizziness.</li>
<li>Be aware that antiemetic action may mask symptoms of unrecognized disease and signs of drug overdosage as well as dizziness,
            vertigo, or tinnitus associated with toxic doses of aspirin or other ototoxic drugs.
         </li>
<li>Patients in pain may develop involuntary (athetoid) movements of upper extremities following parenteral administration. These
            symptoms usually disappear after pain is controlled.
         </li>
<li>Monitor respiratory function in patients with respiratory problems, particularly children. Drug may suppress cough reflex
            and cause thickening of bronchial secretions.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>For motion sickness: Take initial dose 3060 min before anticipated travel and repeat at 812 h intervals if necessary.
            For duration of journey, repeat dose on arising and again at evening meal.
         </li>
<li>Do not drive or engage in other potentially hazardous activities requiring mental alertness and normal reaction time until
            response to drug is known.
         </li>
<li>Avoid sunlamps or prolonged exposure to sunlight. Use sunscreen lotion during initial drug therapy.</li>
<li>Do not take OTC medications without physician's approval.</li>
<li>Avoid alcohol and other CNS depressants.</li>
<li>Relieve dry mouth by frequent rinses with water or by increasing noncaloric fluid intake (if allowed), chewing sugarless gum,
            or sucking hard candy. If these measures fail, add a saliva substitute (e.g., Moi-Stir, Orex, Xero-Lube).
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>